Ausgabe 1/2021
Inhalt (28 Artikel)
Lennox–Gastaut Syndrome: Perspective of a Parent and a Physician
Heather R. McKee, Barbara Glasgow
Globus Pallidus Internus (GPi) Deep Brain Stimulation for Parkinson’s Disease: Expert Review and Commentary
Ka Loong Kelvin Au, Joshua K. Wong, Takashi Tsuboi, Robert S. Eisinger, Kathryn Moore, Janine Lemos Melo Lobo Jofili Lopes, Marshall T. Holland, Vanessa M. Holanda, Zhongxing Peng-Chen, Addie Patterson, Kelly D. Foote, Adolfo Ramirez-Zamora, Michael S. Okun, Leonardo Almeida
Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review
Barry S. Baumel, P. Murali Doraiswamy, Marwan Sabbagh, Richard Wurtman
Targeting of the Subthalamic Nucleus in Patients with Parkinson’s Disease Undergoing Deep Brain Stimulation Surgery
Pepijn van den Munckhof, Maarten Bot, P. Richard Schuurman
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms—A Narrative Review
Lynsey Lakin, Bryan E. Davis, Cherie C. Binns, Keisha M. Currie, Mary R. Rensel
Patient and Provider Insights into the Impact of Multiple Sclerosis on Mental Health: A Narrative Review
Bryan E. Davis, Lynsey Lakin, Cherie C. Binns, Keisha M. Currie, Mary R. Rensel
Long-Term Assessment of Lurasidone in Schizophrenia: Post Hoc Analysis of a 12-Month, Double Blind, Active-Controlled Trial and 6-Month Open-Label Extension Study
Preeya J. Patel, Christian Weidenfeller, Andrew P. Jones, Jens Nilsson, Jay Hsu
Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis
J. Bradford Rice, Mary P. Panaccio, Alan White, Mark Simes, Emma Billmyer, Nathaniel Downes, John Niewoehner, George J. Wan
Effectiveness of Dimethyl Fumarate in Patients With Relapsing Multiple Sclerosis Switching After Suboptimal Response to Glatiramer Acetate, Including Patients With Early Multiple Sclerosis: Subgroup Analysis of RESPOND
Pavle Repovic, Derrick Robertson, Kiren Kresa-Reahl, Stanley L. Cohan, Ray Su, Robin Avila, Irene Koulinska, Jason P. Mendoza
Work Productivity Outcomes Associated with Ocrelizumab Compared with Other Disease-Modifying Therapies for Multiple Sclerosis
Edward E. Neuberger, Ibrahim M. Abbass, Eddie Jones, Natalie J. Engmann
Parent Experiences of Sanfilippo Syndrome Impact and Unmet Treatment Needs: A Qualitative Assessment
Katherine Ackerman Porter, Cara O’Neill, Elise Drake, Samantha Parker, Maria L. Escolar, Stacey Montgomery, William Moon, Carolyn Worrall, Holly L. Peay
Quantifying Knowledge of Alzheimer’s Disease: An Analysis of the Psychometric Properties of the Alzheimer’s Disease Knowledge Scale
Guillermo Garcia-Ribas, Elena García-Arcelay, Alonso Montoya, Jorge Maurino, Javier Ballesteros
Recognition of Facial Emotion Expressions in Patients with Depressive Disorders: A Prospective, Observational Study
Roman Vitalievich Akhapkin, Beatrisa Albertovna Volel, Rodion Mikhailovich Shishorin, Dmitry Vladimirovich Ustyuzhanin, Dmitry Sergeevich Petelin
Ubrogepant for the Acute Treatment of Migraine: Pooled Efficacy, Safety, and Tolerability From the ACHIEVE I and ACHIEVE II Phase 3 Randomized Trials
Susan Hutchinson, David W. Dodick, Christina Treppendahl, Nathan L. Bennett, Sung Yun Yu, Hua Guo, Joel M. Trugman
Global Peginterferon Beta-1a Tolerability Management Best Practices: A Nurse-Focused Delphi Approach
Sarah White, Colleen Harris, Michelle Allan, Carol Chieffe, Piet Eelen, Claudia Röder, Catherine Mouzawak, Maria L. Naylor
Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study
Yoshihisa Tatsuoka, Takao Takeshima, Akichika Ozeki, Taka Matsumura
The COVID-19 Pandemic Experience in Multiple Sclerosis: The Good, the Bad and the Neutral
Hannah Morris-Bankole, Aileen K. Ho
Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers
Elizabeth Faust, Irina Pivneva, Karen Yang, Keith A. Betts, Zubair Ahmed, Shivang Joshi, Rebecca Hogan, Andrew Blumenfeld, Jack Schim, Alexander Feoktistov, Kenneth Carnes, Mark Bensink, Eric Q. Wu, Denise E. Chou, David Chandler
Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia
Shyamal H. Mehta, Rajesh Pahwa, Caroline M. Tanner, Robert A. Hauser, Reed Johnson
STO: Stroke Ontology for Accelerating Translational Stroke Research
Mahdi Habibi-koolaee, Leila Shahmoradi, Sharareh R. Niakan Kalhori, Hossein Ghannadan, Erfan Younesi
The Association Between Dietary Acid Load and Odds of Migraine: A Case–Control Survey
Maryam Mousavi, Soodeh Razeghi Jahromi, Mansoureh Togha, Zeinab Ghorbani, Azita Hekmatdoost, Pegah Rafiee, Boshra Torkan, Pedram Shirani, Hossein Ansari, Ahmadreza Karami, Morvarid Nourmohammadi, Faezeh Khorsha
Multiple Sclerosis Patients Treated With Diroximel Fumarate in the Real-World Setting Have High Rates of Persistence and Adherence
Jacob Liseno, Brittney Lager, Catherine Miller, Sai L. Shankar, Jason P. Mendoza, James B. Lewin
Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)
Marcos Madruga-Garrido, Juan F. Vázquez-Costa, Julita Medina-Cantillo, María Brañas, María G. Cattinari, Mencía de Lemus, Paola Díaz-Abós, Victoria Sánchez-Menéndez, Ángeles Terrancle, Pablo Rebollo, Jorge Maurino
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
Teresa Coelho, Yukio Ando, Merrill D. Benson, John L. Berk, Márcia Waddington-Cruz, Peter J. Dyck, Julian D. Gillmore, Sami L. Khella, William J. Litchy, Laura Obici, Cecilia Monteiro, Li-Jung Tai, Nicholas J. Viney, Gustavo Buchele, Michela Brambatti, Shiangtung W. Jung, Louis St. L. O’Dea, Sotirios Tsimikas, Eugene Schneider, Richard S. Geary, Brett P. Monia, Morie Gertz
Evidence-Based Recommendations for the Oral Health of Patients with Parkinson’s Disease
Ana L. C. Martimbianco, Fabio C. Prosdocimi, Camillo Anauate-Netto, Elaine M. dos Santos, Gustavo D. Mendes, Yara D. Fragoso
Rivaroxaban in Recurrent Ischemic Stroke Due to Protein S Deficiency: A Case Report
Saba Naghavi, Ahmad Pourmohammadi, Iman Adibi
Correction to: A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis
Ivan Urits, Daniel Swanson, Michael C. Swett, Anjana Patel, Kevin Berardino, Ariunzaya Amgalan, Amnon A. Berger, Hisham Kassem, Alan D. Kaye, Omar Viswanath